Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases.

Maselli, Daniel B; Camilleri, Michael

Maselli, Daniel B; Camilleri, Michael.

Afiliación

Maselli DB; Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: camilleri.michael@mayo.edu.

Clin Gastroenterol Hepatol ; 19(9): 1748-1758.e2, 2021 09.

Article en En | MEDLINE | ID: mdl-32673642

Asunto(s)

Cannabinoides; Cannabis; Hepatopatías; Cannabinoides/efectos adversos; Dronabinol; Humanos; Hepatopatías/tratamiento farmacológico; Receptores de Cannabinoides

Palabras clave

2-AG; Anandamide; CBD; DAGL; FAAH; MAGL; THC

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cannabinoides / Cannabis / Hepatopatías Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google